Skip to main content
SpringerLink
Log in

Anticonvulsants in the newborn period

  • Clinical Pharmacology
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Myers GJ, Cassady G: Neonatal seizures. Pediatrics 5: 67, 1983.

    Google Scholar 

  2. Goldberg HJ: Neonatal convulsions—A ten year review.Arch Dis Child 58: 976, 1983

    Article  PubMed  CAS  Google Scholar 

  3. O'Donohoe NV: Epilepsies of Childhood. Butterworths, London. 1979 p 16

    Google Scholar 

  4. Orme MLE: Oral contraceptives and anticonvulsant drugs.Br J Clin Practice Symposium 27: 26, 1982

    Google Scholar 

  5. Sonnen AEH: Sodium valproate and the contraceptive pill.Br J Clin Practice Symposium 27: 31, 1982

    Google Scholar 

  6. British Medical Journal: Leading article—Epilepsy and pregnancy.Br Med J 281: 1087, 1980

    Google Scholar 

  7. British Medical Journal: Leading article—Teratogenic risks of anticonvulsants.Br Med J 283: 515, 1981

    Google Scholar 

  8. Rudd NL, Freedom RL: A possible primidone embryopathy.J Pediatr 94: 835, 1979

    Article  PubMed  CAS  Google Scholar 

  9. Thomas D, Buchanan N: Teratogenic effect of anticonvulsants.J Pediatr 99: 163, 1981

    Article  PubMed  CAS  Google Scholar 

  10. Dalens B, Raynaud EJ, Gauline J: Teratogenicity of valproic acid.J Pediatr 97; 332, 1980

    PubMed  CAS  Google Scholar 

  11. Bgerkedal T, Czeizel A, Goujardj Ket al: Valproic acid and spina bifida.Lancet ii: 1096, 1982

    Article  Google Scholar 

  12. Hiilesmaa VK, Teramo K, Granstom ML, Bardy AH: Fetal head growth associated with maternal antiepileptic drugs.Lancet ii: 165, 1981

    Article  Google Scholar 

  13. Dickinson RG, Harland RC, Lynn RK, Smith WB, Gerber N: Transmission of valproic acid (Depakene) across the placenta: Half life of the drug in mother and baby.J Pediatr 894: 832, 1979

    Google Scholar 

  14. Ishizaki T, Yokochi K, Chiba K, Tabuchi T, Wagamatsuma T: Placental transfer of anticonvulsants (Phenobarbital, phenytoin, valproic acid) and the elimination from neonates.Pediatric Pharmacol 1: 291, 1981

    CAS  Google Scholar 

  15. Nau H, Rating D, Hauser I, Jager E, Koch S, Helge H: Placental transfer of Primidone and its metabolites Phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers.Eur J Clin Pharmacol 18, 31, 1980

    Article  PubMed  CAS  Google Scholar 

  16. Wilson JT: Drugs in breast milk. ADJS Press, Auckland 1981

    Google Scholar 

  17. Shanker LS: Drug absorption: Fundamentals of Drug Metabolism and Drug Disposition. La Du, Mandel and Way (Eds); Williams and Wilkins, Baltimore, 1971

    Google Scholar 

  18. Yaffe SJ, Jucau MR: Perinatal pharmacology.Ann Rev Pharmacol,14: 219, 1974

    Article  CAS  Google Scholar 

  19. Smith CA:The physiology of the newborn infant. Thomas, Springfield, 1951. p 180

    Google Scholar 

  20. Boreus LO, Jalling B, Kallberg N: Clinical Pharmacology of phenobarbital in the neonatal period.In Basic and Therapeutic aspects of Perinatal Pharmacology Morselli, Garattini and Serini (Eds); Raven Press, New York, 1975 p 331

    Google Scholar 

  21. Jalling B, Boreus LO, Rane A, Sjoqvist F: Plasma concentrations of diphenylhydantoin in young infants.Pharmacological Clinical 2: 200, 1970

    Article  Google Scholar 

  22. Albani M, Wernicke I: Oral phenytoin in infancy dose requirement, absorption and elimination.Pediatric Pharmacol 3; 229, 1983

    CAS  Google Scholar 

  23. Morselli PL: Clinical pharmacokinetics in neonates.Clinical Pharmacokinetics 1: 81, 1976

    Article  PubMed  CAS  Google Scholar 

  24. Nau H, Luck W, Kuhnz W, Wegener S: Serum protein binding of diazepam, desmethyldiazepam, furosemide, warfarin and phenobarbital in human fetus, mother and newborn infant.Pediatric Pharmacol 3: 219, 1983

    CAS  Google Scholar 

  25. Taburet AM, Chamouard C, Aymard P, Chevalier JY, Costil J: Phenobarbital protein binding in neonates.Dev Pharmacol Ther 4: 129, 1982

    PubMed  Google Scholar 

  26. Kuhnz W, Steldinger R, Nau H: Protein binding of carbamazepine and its epoxide in maternal and fetal plasma at delivery: comparison to other anticonvulsants.Dev Pharmacol Ther 7: 61, 1984

    PubMed  CAS  Google Scholar 

  27. Rane A, Tomson G: Prenatal and neonatal drug metabolism in man.Eur J Clin Pharmacol 18; 9, 1980

    Article  PubMed  CAS  Google Scholar 

  28. Neims AH, Warner M, Loughnan PM, Aranda JV: Development aspects of the hepatic cytochrome P 450 monooxygenase system.Ann Rev Pharmacol Toxicol 16; 427, 1976

    Article  CAS  Google Scholar 

  29. Boreus LO:Principles of Pediatric Pharmacology. Churchill Livingstone, Edinburgh, 1982 p 91

    Google Scholar 

  30. Short CR, Kinden D, Stith R: Fetal and neonatal development of the microsomal monooxygenase system.Drug Metab Rev 5: 1, 1976

    Article  CAS  Google Scholar 

  31. Boreus LO, Jalling B, Kallberg N: Phenobarbital metabolism in adults and newborn infants.Acta Pediatr Scand 67: 193, 1978

    Article  CAS  Google Scholar 

  32. Pitlick W, Painter MJ, Pippenger C: Phenobarbital kinetics in neonates.Clin Pharmacol Ther 23: 346, 1978

    PubMed  CAS  Google Scholar 

  33. Painter MJ, Pippenger C, MacDonald H, Pitlick W: Phenobarbitone and diphenylhydandtoin levels in neonates with seizures.J Pediatr 92: 315, 1978

    Article  PubMed  CAS  Google Scholar 

  34. Rane A: Urinary excretion of diphenylhydantoin metabolites in newborn infants.J Pediatr 85: 543, 1974

    Article  PubMed  CAS  Google Scholar 

  35. Morselli PL, Principi N, Tognoni G, Reali E, Belvedere G, Strauden SM, Serini F. Diazepam elimination in premature and full term infants and children.J Perinatal Med 1: 133, 1973

    CAS  Google Scholar 

  36. Rane A, Bertilsson L, Palmer L: Disposition of placentally transferred carbamazepine (Tegretol) in the newborn.Eur J Clin Pharmacol 8: 283, 1975

    Article  PubMed  CAS  Google Scholar 

  37. Rey E, D'Athis P, de Lauture D, Dulac O, Aicardi J, Olive G: Pharmacokinetics of carbamazepine in the neonate and in the child.Int J Clin Pharmacol Biopharm. 17: 90, 1979

    PubMed  CAS  Google Scholar 

  38. Rating D, Jager-Roman E, Nau H, Kuhnz H, Helge H: Enzyme induction in neonates after fetal exposure to antiepileptic drugsPediatric Pharmacol 3: 209, 1983

    CAS  Google Scholar 

  39. Doyle PE, Jager-Roman E, Baird-Lambert J, Cvejic M, Buchanan N: Effect of prenatal exposure to betamethasone on metronidazole elimination in premature infants.J Pediatr 101: 647, 1982

    PubMed  CAS  Google Scholar 

  40. Jager-Roman E, Doyle PE, Thomas D, Baird-Lambert J, Cvejic M, Buchanan N: Increased theophylline metabolism in premature infants after prenatal betamethasone administration.Dev Pharmacol Ther 5: 127 1982

    PubMed  CAS  Google Scholar 

  41. Lancet: Leading article—Cimetidine and ranitidine.Lancet i: 601, 1982

    Google Scholar 

  42. Braunich H. Kidney development—drug elimination mechanisms.In Drug disposition during development Morselli (Ed); Spectrum, New York, Chapter 6, 1979

    Google Scholar 

  43. Aperia A, Broberger O, Elender G, Herin P, Zetterstrom R: Postnatal development of renal function in preterm and full term infants.Acta Pediatr Scand 70: 183, 1981

    Article  CAS  Google Scholar 

  44. Strauss J, Daniel SS, James LS: Postnatal adjustment in renal function.Pediatrics 68: 802, 1981

    PubMed  CAS  Google Scholar 

  45. Jeavons PM: Non-dose related side effects of valproate.Epilepsia 25: 550, 1984

    Article  Google Scholar 

  46. Felding I, Rane A: Congenital liver damage after treatment of mother with valproic acid and phenytoin.Acta Pediatr Scand 73: 565, 1984

    Article  CAS  Google Scholar 

  47. Nau H, Rating D, Koch S, Hauser I, Helge H: Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers.J Exp Pharmacol Ther 219: 768, 1981

    CAS  Google Scholar 

  48. Nau H, Helge H, Luck W: Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and its metabolites.J Pediatr 104: 627, 1984

    Article  PubMed  CAS  Google Scholar 

  49. Viani F, Jussi MI, Germano M, Lotti P, Lotti F: Rectal administration of sodium valproate for neonatal and infantile status epilepticus.Dev Med Child Neurol 26: 678, 1984

    Article  PubMed  CAS  Google Scholar 

  50. Kanto J, Erkkola R, Sellman R: Distribution and metabolism of diazepam in early and late human pregnancy. Postnatal metabolism of diazepam.Acta Pharmacol Toxicol 35: 36, 1984

    Google Scholar 

  51. Ackermann E, Richter K: Diazepam metabolism in human foetal and adult liver.Eur J Clin Pharmacol 11: 43, 1977

    Article  PubMed  CAS  Google Scholar 

  52. Mandelli M, Morselli P, Nordio S, Pardi G, Principi N, Sereni, F, Tognoni G: Placental transfer of diazepam and its disposition in the newborn.Clin Pharmacol Ther 17: 564, 1975

    PubMed  CAS  Google Scholar 

  53. Nau H, Luck W, Kuhnz W: Decreased serum protein binding of diazepam and its major metabolites during the first postnatal week related to increased free fatty acid levels.Br J Clin Pharmacol 17: 92, 1984

    PubMed  CAS  Google Scholar 

  54. Dulac O, Aicardi J, Rey E, Olive G: Blood levels of diazepam after single rectal administration in infants and children.J Pediatr 93: 1039, 1978

    Article  PubMed  CAS  Google Scholar 

  55. Tekur U, Gupta A, Tayal G, Agarwal KK: Blood concentrations of diazepam and its metabolites in children and neonates with tetanus.J Pediatr 102: 145, 1983

    Article  PubMed  CAS  Google Scholar 

  56. Chiba K, Ishizaki T, Miura H, Minagawa K: Michaelis Menten pharmacokinetics of diphenylhydantion and application in the paediatric age patient.J Pediatr,96: 479, 1980

    Article  PubMed  CAS  Google Scholar 

  57. Dodson EW: Phenytoin kinetics in children.Clin Pharmacol Ther 1980, 27: 704, 1980

    Article  PubMed  CAS  Google Scholar 

  58. Chia K, Ishizaki T, Miura H, Minagawaka K: Apparent Michaelis Menten kinetic parameters of phenytoin in paediatric patients.Pediatric Pharmacol 1: 171, 1980

    Google Scholar 

  59. Jalling B. Plasma concentrations of phenobarbital in the treatment of seizures in newborns.Acta Pediatr Scand 64: 514, 524 1975

    Article  CAS  Google Scholar 

  60. Royer RJ, Vert P, Mur JM, Pladys JC, Humbert F, Royer Morrot MJ: Donnees pharmacocietiques sur le phenobarbital. Etude de I'influence de l'age gestationnel et de la dysmaturite.Archives Francaises de Pediatrie 33: 905–913 1976

    PubMed  CAS  Google Scholar 

  61. Lockman LA, Kriel R, Zaske D, Thompson T, Virnig N: Phenobarbital dosage for control of neonatal seizures.Neurology 29: 1445, 1979

    PubMed  CAS  Google Scholar 

  62. Fischer JH, Lockman LA, Zaske D, Kriel R: Phenobarbital maintenance dose requirements in treating neonatal seizures.Neurology 31: 1042, 1981

    PubMed  CAS  Google Scholar 

  63. Gal P, Toback J, Boer HR, Erkan NV, Wells TJ. Efficacy of phenobarbital monotherapy in treatment of neonatal seizures-relationship to blood levels.Neurology 32: 1401, 1982

    PubMed  CAS  Google Scholar 

  64. Gal P, Toback J, Erkan NV, Boer HR: The influence of asphyxia on phenobarbital dosing requirements in neonates.Dev Pharmacol Ther 7: 145, 1984

    PubMed  CAS  Google Scholar 

  65. Myers MG, Robert RJ, Mirkij NJ: Effects of gestational age, birthweight and hypoxaemia on the pharmacokinetics of amikacin in serum of infants.Antimicrob agents Chemother 11: 1027, 1977

    PubMed  CAS  Google Scholar 

  66. Gal P, Boer HR, Toback J, Erkan NV: Effect of asphyxia on theophylline clearance in newborns.Southern Med J 75: 836, 1982

    CAS  PubMed  Google Scholar 

  67. Gal P, Boer HR, Toback J, Erkand NV: Phenobarbital dosing in neonates and asphyxia.Neurology 32: 788, 1982

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Pharmacology Unit, Department of Pediatrics, University of Sydney, Australia

    Neil Buchnan Ph.D. F.R.A.C.P.

Authors
  1. Neil Buchnan Ph.D. F.R.A.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buchnan, N. Anticonvulsants in the newborn period. Indian J Pediatr 52, 513–526 (1985). https://doi.org/10.1007/BF02751028

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02751028

Keywords

Search

Navigation